Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/01/24 07:30:05 on US and Canada Markets.
2024-04-01 07:30:05 ET Wells Fargo analyst issues OVERWEIGHT recommendation for SITE on April 1, 2024 05:49AM ET. The previous analyst recommendation was Overweight. SITE was trading at $174.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-04-01 07:30:05 ET Wells Fargo analyst issues OVERWEIGHT recommendation for ANNX on April 1, 2024 05:50AM ET. The previous analyst recommendation was Overweight. ANNX was trading at $7.17 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Freedom Capital Markets NYC Family Office Summit Attendance Also on CEO Schedule Freedom Holding Corp. (NASDAQ: FRHC) (the "Company"), a multi-national diversified financial services holding company, announced today that Timur Turlov, Chief Executive Officer and Founder, is scheduled ...
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2024) - Pacific Empire Minerals Corp. (TSXV: PEMC) ("Pacific Empire", "PEMC" or the "Company"), a British Columbia copper-gold explorer, announces Expert Geophysics Ltd. ("Expert") has now completed an airborne MobileMT™ survey at its...
INDEPENDENT PROXY ADVISOR, INSTITUTIONAL SHAREHOLDER SERVICES ("ISS"), RECOMMENDS CANOPY GROWTH SHAREHOLDERS VOTE FOR THE CREATION OF EXCHANGEABLE SHARES TO FURTHER THE ADVANCEMENT OF CANOPY USA Canada NewsWire Shareholders are encouraged to vote well in advance of the proxy v...
W. P. Carey Releases 2023 CEO Letter PR Newswire NEW YORK , April 1, 2024 /PRNewswire/ -- W. P. Carey (W. P. Carey, NYSE: WPC), a leading net lease REIT specializing in corporate sale-leasebacks, build-to-suits and the acquisition of single-tenant net lease pro...
Generac Appoints Jennifer Anderson as Executive Vice President of Global Corporate Strategy & Development Generac Appoints Jennifer Anderson as Executive Vice President of Global Corporate Strategy & Development PR Newswire WAUKESHA, Wis. , April 1, 2024 ...
- Company Now Exclusively Focused on Development and Commercialization of Abecma - 2seventy bio, Inc . (Nasdaq: TSVT), announced today the completion of the asset purchase agreement (“APA”) by Regeneron Pharmaceuticals, Inc. Under the terms of the APA, Regeneron has ac...
PHILADELPHIA, April 01, 2024 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that on March 28, 2024, the Company submitted an Investigational Ne...
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRAS G12C -Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Zai L...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
16.47%Change Percent:
Moderna Inc. Company Name:
MRNA Stock Symbol:
NASDAQ Market:
modernatx.com Website: